FINASTERIDE

Post-LOE

finasteride

ANDAORALTABLET
Approved
Dec 2006
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
9

Clinical Trials (5)

NCT01534351Phase 3Terminated

Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)

Started Aug 2013
1 enrolled
Benign Prostatic Hyperplasia
NCT01231607Phase 3Completed

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

Started Oct 2010
917 enrolled
Androgenetic Alopecia
NCT01139762Phase 3Completed

A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms

Started Sep 2010
696 enrolled
Benign Prostatic HyperplasiaEnlarged Prostate
NCT00600691Phase 2Terminated

The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy

Started Mar 2008
29 enrolled
HematuriaHematospermia
NCT00564460Phase 3Withdrawn

On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)

Started Feb 2008
Benign Prostatic Hyperplasia